An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport

Details for Australian Patent Application No. 2003241629 (hide)

Owner AstraZeneca AB

Inventors Ungell, Anna-Lena; Lindqvist, AnnMargret; Abrahamsson, Bertil

Agent Davies Collison Cave

Pub. Number AU-B-2003241629

Parent 46335

Filing date 27 August 2003

Wipo publication date 18 September 2003

Acceptance publication date 16 June 2005

International Classifications

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

A61P 003/06 Drugs for disorders of the metabolism

A61K 009/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

Event Publications

11 September 2003 Complete Application Filed

18 September 2003 Application Open to Public Inspection

  Published as AU-B-2003241629

16 June 2005 Application Accepted

  Published as AU-B-2003241629

13 October 2005 Standard Patent Sealed

29 November 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003241630-A hopper for discs

2003241628-DUAL USE DUAL COMPLEX MULTIPLIER AND COMPLEX DIVIDER